BioXcel's agitation drug meets main goal in at-home study-March 2024-www.financetom.com

BioXcel's agitation drug meets main goal in at-home study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BioXcel's agitation drug meets main goal in at-home study

Aug 27, 2025 4:36 AM

Aug 27 (Reuters) - BioXcel Therapeutics ( BTAI ) said on

Wednesday its experimental agitation drug met the main goal of a

late-stage study testing it in patients with bipolar disorder or

schizophrenia for at-home use.

Previous page： Next page： F&G Annuities & Life Q1 Adjusted EPS, Revenue Increase

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

May 8, 2024

...

F&G Annuities & Life Q1 Adjusted EPS, Revenue Increase

May 8, 2024

05:47 PM EDT, 05/08/2024 (MT Newswires) -- F&G Annuities & Life ( FG ) late Wednesday reported Q1 adjusted net income of $0.86 per diluted share, up from $0.49 a year earlier. Two analysts polled by Capital IQ expected $1.01. Revenue for the quarter ended March 31 was $1.57 billion, up from $869 million a year earlier. Analysts expected $1.17...

Hca Healthcare Insider Sold Shares Worth $494,400, According to a Recent SEC Filing

May 8, 2024

05:48 PM EDT, 05/08/2024 (MT Newswires) -- Michael S. Cuffe, Executive Vice President and Chief Clinical Officer, on May 06, 2024, sold 1,600 shares in Hca Healthcare ( HCA ) for $494,400. Following the Form 4 filing with the SEC, Cuffe has control over a total of 34,124 shares of the company, with 34,124 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/860730/000120919124005570/xslF345X03/doc4.xml...

Celanese beats quarterly profit estimates as demand picks up

May 8, 2024

May 8 (Reuters) - Chemicals maker Celanese beat first-quarter profit estimates on Wednesday, helped by a steady rise in demand for its products amid persistent destocking trends. Destocking, a process by which companies offload excess inventory, had plagued chemicals companies amid soft demand. This trend, however, is expected to slow down this year as demand picks up in key regions...